Catalent eyes acquisitions in emerging market and drug delivery expansion

By Nick Taylor

- Last updated on GMT

Related tags Investment

Catalent is considering acquisitions as it adds scale, drug delivery technologies and capacity in emerging markets.

The shift towards more strategic outsourcing and greater reliance on vendors is driving pursuit of scale, geographic reach and advanced capabilities at Catalent. To meet some of these goals Catalent made a $410m (€296m) move for Aptuit’s clinical trial supply assets and further deals are possible.

If there’s an opportunity for us to pick up an inorganic acquisition at the right time and the right place we will certainly do that​”, Scott Houlton, president, development and clinical services at Catalent, told Outsourcing-Pharma.

Houlton outlined areas of expansion at Catalent: “We will continue to invest in drug delivery technologies and also in scale. I think there are opportunities for us to look at the emerging markets, within China, India, other locations​.”

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 04-May-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

cGMP Assurance of Supply Services Case Study

cGMP Assurance of Supply Services Case Study

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Apr-2023 | Case Study

Having the right raw materials available for production when they’re needed is imperative, as delays can negatively impact production schedules. Manufacturers...

Related suppliers

Follow us

Products

View more

Webinars